• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Streamex Corp. Announces 24/7, 365 Instant Liquidity for GLDY Through Collaboration with Wintermute

    7/23/26 7:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $STEX alert in real time by email

    Highlights

    • Buying or selling GLDY is now instant. With Wintermute acting as a continuous liquidity provider, both purchases and redemptions of GLDY now complete in real time, T+0. What previously took two business days now happens immediately, around the clock, 365 days a year.
    • GLDY now has approximately $12 million in secondary market liquidity across multiple avenues, available 24/7, 365.



    WINTER PARK, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the future of the commodity markets through tokenization, today announced that Wintermute, an independent third-party proprietary trading firm, has expanded liquidity for GLDY, the Company’s gold-backed, yield-bearing tokenized security. Under the arrangement, eligible GLDY holders can now access instant third-party liquidity through our interface.

    Streamex has seeded 1,069 GLDY and $5,000,000 USDC with Wintermute, bringing total secondary market liquidity to approximately $12 million USD across multiple venues.

    The addition of Wintermute as a liquidity provider is designed to improve the GLDY investor experience. Previously, both the purchase and redemption process for GLDY settled on a T+2 basis, a two-business-day clearing cycle consistent with traditional securities markets. Now, both processes settle instantly at T+0. An investor who decides to buy or sell GLDY today does not wait, the transaction clears immediately, in real time, within approximately 10 bps of the spot gold market price, supported by institutional infrastructure, subject to market conditions, applicable liquidity limits, and the functionality of third-party blockchain infrastructure.

    For all investors, Wintermute’s liquidity will be available directly through the Streamex platform, enabling purchases and redemptions to be executed natively within the Streamex application, streamlining the investor experience from discovery to settlement in a single interface.

    Combined with the Orca permissioned pool infrastructure, and tZero’s ATS, GLDY’s total secondary market liquidity now stands at approximately $12 million. Investors can access this liquidity on their own schedule, not during exchange hours, not subject to T+2 clearing, but continuously and immediately.

    Investor Questions: What You Need to Know

    Is there a limit on how much I can buy or sell at once?

    Individual orders through the Streamex interface are subject to a maximum of 1,000 GLDY tokens or $4.5 million USD per 48-hour period. Institutional investors seeking to transact above these thresholds may do so directly OTC with Wintermute.

    How long does it take?

    Instant. Both purchases and redemptions through Wintermute settle in real time at T+0. There is no waiting period.

    Does this cost anything extra?

    There is no added trading fee. As with any market, transactions are subject to a bid-ask spread, which varies based on order size and market conditions. No additional fees are charged beyond the spread.

    Is this available right now?

    Yes. Wintermute began quoting prices and bid/ask spreads for GLDY as of last week. The liquidity is live.

    Henry McPhie, Co-Founder & Chief Executive Officer of Streamex, said:

    "T+0 settlement is something traditional financial markets have spent years working toward for equities. GLDY has it today, for a tokenized gold security. What that means in practice is simple: investors are no longer waiting two days to have their transaction cleared. They buy, they own. They sell, they receive proceeds. That is how it should work, and that is now how GLDY works."

    About Wintermute

    Wintermute is one of the world’s leading algorithmic trading and market-making firms, providing liquidity across major centralized exchanges, decentralized protocols, and OTC markets globally. Wintermute operates 24/7 across digital asset markets, supporting institutional and retail trading ecosystems with continuous two-sided liquidity. For more information, visit wintermute.com.

    About Streamex Corp.

    Streamex Corp. (NASDAQ:STEX) is a technology and infrastructure company focused on the tokenization and digitalization of commodity real-world assets. Streamex delivers institutional-grade solutions that bridge traditional finance and blockchain-enabled markets through secure, regulated, and yield-bearing financial instruments.

    For more information, visit www.streamex.com.

    Forward-Looking Statements & Disclaimer

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Streamex’s business strategy, future growth, product development, secondary market activity, liquidity availability, and the expected performance and adoption of GLDY. These statements are based on current expectations and assumptions that are subject to risks and uncertainties, many of which are beyond Streamex’s control, and actual results may differ materially. The availability of liquidity through Wintermute and other venues is subject to market conditions, applicable liquidity limits, and the continued operation of third-party infrastructure. Factors that could cause results to differ materially include, among others, market conditions, regulatory developments, and macroeconomic factors affecting digital asset and commodity markets. A discussion of these and other factors is set forth in Streamex’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, as may be supplemented or updated by Streamex’s Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Streamex undertakes no obligation to update or revise any forward-looking statements except as required by applicable law.

    Wintermute is an independent third-party proprietary trading firm and is not acting as Streamex’s broker, underwriter, or placement agent. Streamex does not direct Wintermute’s quotes, trading decisions, or spreads, and Streamex does not guarantee that any holder will be able to purchase, sell, redeem, or settle GLDY at any particular time, size, price, spread, or settlement speed.

    Contacts

    Streamex Press & Investor Relations

    Adele Carey – Alliance Advisors Investor Relations

    IR@streamex.com | acarey@allianceadvisors.com

    Henry McPhie

    Chief Executive Officer, Streamex Corp.

    www.streamex.com | X.com/streamex

    A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/6d4fdb82-3fdd-460b-ac78-80dc1d08f777



    Primary Logo

    Get the next $STEX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $STEX

    DatePrice TargetRatingAnalyst
    11/25/2025$12.00Buy
    Needham
    More analyst ratings

    $STEX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Matthews Shawn was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    7/10/26 5:00:04 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Director Gopaul Kevin Roy was granted 100,000 shares, increasing direct ownership by 100% to 200,000 units (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    7/10/26 5:00:03 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,750 worth of shares (50,000 units at $0.99) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    6/15/26 1:21:02 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,750 worth of shares (50,000 units at $0.99) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    6/15/26 1:21:02 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: Interim Executive Chairman Lekstrom Morgan Lee bought $147,289 worth of shares (47,000 units at $3.13) (SEC Form 4)

    4/A - Streamex Corp. (0001530766) (Issuer)

    5/28/26 9:43:32 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Interim Executive Chairman Lekstrom Morgan Lee bought $49,980 worth of shares (34,000 units at $1.47) (SEC Form 4)

    4 - Streamex Corp. (0001530766) (Issuer)

    5/28/26 2:33:28 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    SEC Filings

    View All

    Streamex Corp. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    7/13/26 5:19:19 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/28/26 4:05:31 PM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Streamex Corp. (0001530766) (Filer)

    5/27/26 6:05:10 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Streamex Corp. Details GLDY’s Liquidity Infrastructure; ~$12 Million in Seeded Liquidity Supports 24/7, 365 Instant Trading Across Multiple Institutional-Grade Venues

    The Short VersionWhen you invest in something, one of the first things you want to know is: if I need my money back, can I get it? Streamex built GLDY so that it can be bought or sold at any time, day or night, any day of the year. The sections below explain exactly how that works through GLDY’s multiple layers liquidity. WINTER PARK, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the future of the commodity markets through tokenization, today published a comprehensive overview of the liquidity infrastructure supporting GLDY, a gold-backed, yield-bearing asset offered by Streamex Ltd. (the "Company"). Liqui

    7/23/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces 24/7, 365 Instant Liquidity for GLDY Through Collaboration with Wintermute

    Highlights Buying or selling GLDY is now instant. With Wintermute acting as a continuous liquidity provider, both purchases and redemptions of GLDY now complete in real time, T+0. What previously took two business days now happens immediately, around the clock, 365 days a year.GLDY now has approximately $12 million in secondary market liquidity across multiple avenues, available 24/7, 365. WINTER PARK, Fla., July 23, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the future of the commodity markets through tokenization, today announced that Wintermute, an independent third-party proprietary trading firm, has expanded liq

    7/23/26 7:00:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces GLDY Now Available for Custody by Inspira Financial, Unlocking Yield-Bearing Gold Exposure for Traditional Finance Investors

    Highlights GLDY Class B shares are now available for custody by Inspira Financial, a qualified custodian under the SEC's Custody Rule. Institutional investors, RIA’s, wealth managers, and advisors who hold client assets within Inspira can now access GLDY through infrastructure they already use.Inspira Financial holds over $63 billion in assets across more than 8 million accounts and has serviced over 1,500 funds. As one of the largest directed custodians in the country, Inspira gives GLDY access to an established institutional custody network with deep reach into the traditional finance capital market, representing a significant step-change in GLDY's addressable distribution.Inspira is the

    7/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Streamex Exchange Corporation with a new price target

    Needham initiated coverage of Streamex Exchange Corporation with a rating of Buy and set a new price target of $12.00

    11/25/25 7:59:34 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Financials

    Live finance-specific insights

    View All

    Streamex Corp. Announces June 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., July 17, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the fourth yield payment for GLDY, its yield-bearing gold asset, occurred on July 17th, 2026. The distribution covers the period from June 1st through June 30th, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Each GLDY token is currently earning an ann

    7/17/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY

    WINTER PARK, Fla., June 22, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the distribution of the third yield payment for GLDY, its gold-backed, yield-bearing tokenized security, occurred on June 18th, 2026. The distribution covers the period from May 1st through May 31st, 2026. Yield Distribution Details GLDY's real-world yield is generated through Streamex's institutional gold leasing program, with proceeds from the program distributed to GLDY holders in the form of additional GLDY tokens monthly. Each GLDY token is curren

    6/22/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Provides Q1 2026 Earnings and Corporate Update Presentation Recap; Highlights New Partnerships & Key Updates

    WINTER PARK, Fla., May 21, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company focused on the tokenization of commodity real-world assets, yesterday hosted its Q1 2026 Earnings and Corporate Update Presentation, featuring remarks from Executive Chairman Morgan Lekstrom, Chief Executive Officer Henry McPhie, Chief Financial Officer Christine Plummer, and Chief Investment Officer Mitch Williams. The following is a summary of the key topics covered. Highlights Equity Trust - access to $72B+ and 359,000 U.S. tax-advantaged retirement accounts. An upcoming integration with Equity Trust Company opens GLDY to a distribution channel that prev

    5/21/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $STEX
    Leadership Updates

    Live Leadership Updates

    View All

    Streamex Corp. Appoints Former Microsoft and PayPal Lead Product Designer Kori Handy as Vice President of Product and Design

    WINTER PARK, Fla., May 26, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology company building the tokenization ecosystem for all real-world assets beginning with commodities, today announced the appointment of Kori Handy as Vice President of Product and Design. Kori brings 18 years of experience scaling fintech and SaaS platforms from zero to $2B+ in assets under management and more than 200 million users, and joins Streamex at a pivotal moment in the Company's growth trajectory. Highlights Kori brings nearly two decades of product, design, and startup leadership experience building fintech and SaaS platforms used by more than 200 million p

    5/26/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Christine Plummer, Former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer

    WINTER PARK, Fla., March 16, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a technology and infrastructure company focused on the tokenization of commodity real-world assets, today announced the appointment of Christine Plummer, former Global Controller at Coinbase and Managing Director at Morgan Stanley, as Chief Financial Officer of Streamex. In this role, Ms. Plummer is expected to oversee the Company's global finance organization, including financial reporting, regulatory compliance, and financial operations as Streamex continues expanding its institutional platform and launching tokenized commodity products. Henry McPhie, Co-Founder & CEO of Str

    3/16/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Streamex Corp. Appoints Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. & Founder and CIO of Hondius Capital Management, to Board of Directors

    WINTER PARK, Fla., March 03, 2026 (GLOBE NEWSWIRE) -- Streamex Corp. ("Streamex" or the "Company") (NASDAQ:STEX), a leader in institutional-grade tokenization and digital asset infrastructure, today is excited to announce the appointment of Shawn Matthews, Former CEO of Cantor Fitzgerald & Co. and Founder and Chief Investment Officer of Hondius Capital Management, to its Board of Directors. In this role, Mr. Matthews will bring decades of global investment, trading, and executive leadership experience to support Streamex's strategic growth, capital markets initiatives, and governance. He is joining as an independent director. Morgan Lekstrom, Co-Founder & Executive Chairman of Streamex sa

    3/3/26 7:30:00 AM ET
    $STEX
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care